SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

FIIs increase stake in Lupin to 31.45%

09 Oct 2013 Evaluate

Foreign institutional investors (FIIs) have increased their stake in Lupin by around one percent to 31.45% in September 2013 quarter. The overseas investors raised their holdings in the company by 4 percentage points so far in the current calendar year 2013. The overseas investors held 27.76% stake in the company in December 2012 quarter.

The company had already received its board’s approval to increase limit of investments by FIIs in the equity share capital of the company from 33% to 49%, subject to regulatory approval.

Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded and generic formulations and APIs globally.

 

Lupin Share Price

2249.70 -128.20 (-5.39%)
11-May-2026 15:49 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.40
Dr. Reddys Lab 1282.15
Cipla 1304.70
Zydus Lifesciences 960.00
Lupin 2249.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×